Table 2.
The general proportion of antimicrobial susceptibility test among Salmonella isolates.
| Antimicrobials | Antimicrobial susceptibility test | ||
|---|---|---|---|
| Susceptible (%) | Intermediate (%) | Resistant (%) | |
| Amoxicillin (AML) | 16 (76.2) | 3 (14.3) | 2 (9.5) |
| Ampicillin (AMP) | 15 (71.4) | 3 (14.3) | 3 (14.3) |
| Cephalothin (KF) | 16 (76.2) | 4 (19) | 1 (4.8) |
| Ceftriaxone (CRO) | 21 (100) | 0 | 0 |
| Gentamicin (CN) | 19 (90.5) | 0 | 2 (9.5) |
| Nalidixic acid (NA) | 19 (90.5) | 0 | 2 (9.5) |
| Nitrofurantoin (F) | 15 (71.4) | 4 (19) | 2 (9.5) |
| Sulfamethoxazole-trimethoprim (SXT) | 15 (71.4) | 0 | 6 (28.6) |
| Tetracycline (TE) | 10 (47.6) | 2 (9.5) | 9 (42.6) |